echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Sub-Journal: What is the treatment burden for patients with refractory symptomatic epilepsy?

    JAMA Sub-Journal: What is the treatment burden for patients with refractory symptomatic epilepsy?

    • Last Update: 2021-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    medsci.


    medsci.


    Symptomatic epilepsy (SE) is also called secondary epilepsy.


    Symptomatic epilepsy (SE) is also called secondary epilepsy.


    1.


    2.


    Stateful epilepsy (SE) is associated with poor clinical outcomes and high costs.


    The increase in the degree of refractory SE requires the use of additional drug treatment and increases the morbidity and mortality rate, and the increase in the degree of refractory SE requires the use of additional drug treatment and the increase in morbidity and mortality.


    JAMA

    Patients are classified according to the use of antiepileptic drugs given during hospitalization.


    The main experimental results include discharge treatment, hospital stay, ICU stay, hospital treatment expenses (total expenses and daily expenses).


    Overall, the in-hospital mortality rate was 11.


    Compared with moderate (6.


    The researchers pointed out that symptomatic epilepsy clearly continues to impose a huge burden on patients and the US health system.


    references:

    Guterman EL, Betjemann JP, Aimetti A, et al.


    com/journals/jamaneurology/article-abstract/2777805" target="_blank" rel="noopener">Association Between Treatment Progression, Disease Refractoriness, and Burden of Illness Among Hospitalized Patients With Status Epilepticus.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.